Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Here's 1 Doctor's Biggest Worry About COVID Vaccination

By Keith Speights - Dec 20, 2020 at 9:30AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Hint: It has nothing to do with people who get the vaccines.

The first Americans have already begun to receive Pfizer's ( PFE 1.77% ) COVID-19 vaccine. Another vaccine could be available in a matter of days. In this Motley Fool Live video recorded on Dec. 11, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina talked with immunotherapy scientist Dr. Leo Nissola about the effort to vaccinate people across the U.S. and what his biggest worry about COVID vaccination is.

Corrine Cardina: As we move into the world of vaccination, which is quite different from the world of vaccine development, what would you say is the biggest worry you have about trying to get as many people vaccinated as possible? Is it the logistics and the challenges of distribution? Or are you more concerned about convincing people to take the vaccine?

Dr. Leo Nissola: Thank you for asking this question. I've been dying to answer that question to someone and I've been literally screaming from the top of my lungs here on it.

You see, I think that now we live in an online world and our lives have shifted online. While we are still doing a lot of meaningful work, we also have to be mindful that a lot of people are exposed to false information online. They're exposed to misinformation campaigns about vaccinations, they're exposed to false news on social media and groups from social media platforms.

My biggest worry, and I've written on this in the past few weeks, is that folks at home do not have confidence in our decision-makers and I think we have to rebuild that trust. If I were in any position to make my voice heard there, it would be, please make sure that we have a strong and robust vaccination campaign where we explain to the population not only that the vaccine is safe and effective, but also the benefits of getting a vaccine.

I also called out for a vaccine stimulus. I believe in it. I think it would help folks get on board. I don't agree with the strategy of making those limiting services, limiting people from flying or limiting people that are not vaccinated to get in schools. But I actually think that we should get people excited about the vaccine. Explain for the population, what are the side effects, what are the downsides, what are the possibilities, but also all the benefits.

I think we've lost, I think 12 million people, if I'm not mistaken, have lost their jobs this year, and with their jobs went away their healthcare. It would be an interesting strategy to perhaps give folks at home that have lost their jobs, their healthcare benefits if they choose to take the vaccine.

Corrine Cardina: Absolutely. That's a very innovative idea.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$54.68 (1.77%) $0.95

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
656%
 
S&P 500 Returns
144%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/02/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.